Literature DB >> 21861208

Dipyridamole reversal using theophylline during aminophylline shortage.

Nils P Johnson, K Lance Gould.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21861208     DOI: 10.1007/s12350-011-9445-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  4 in total

1.  Effects of dipyridamole and theophylline on reactive hyperaemia in subcutaneous adipose tissue in humans.

Authors:  B Linde; A Sollevi
Journal:  Clin Physiol       Date:  1987-08

2.  The role of adenosine and prostacyclin in coronary flow regulation in healthy man.

Authors:  A Edlund; A Sollevi; A Wennmalm
Journal:  Acta Physiol Scand       Date:  1989-01

3.  Theophylline antagonizes cardiovascular responses to dipyridamole in man without affecting increases in plasma adenosine.

Authors:  A Sollevi; J Ostergren; B Fagrell; P Hjemdahl
Journal:  Acta Physiol Scand       Date:  1984-06

4.  Hemodynamic changes during dipyridamole stress in patients with aortic stenosis.

Authors:  L P Rask; K H Karp; D E Teien
Journal:  J Heart Valve Dis       Date:  1994-09
  4 in total
  3 in total

Review 1.  Myocardial CT perfusion imaging for ischemia detection.

Authors:  Patricia Carrascosa; Carlos Capunay
Journal:  Cardiovasc Diagn Ther       Date:  2017-04

Review 2.  Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR.

Authors:  Aiden Abidov; Vasken Dilsizian; Rami Doukky; W Lane Duvall; Christopher Dyke; Michael D Elliott; Fadi G Hage; Milena J Henzlova; Nils P Johnson; Ronald G Schwartz; Gregory S Thomas; Andrew J Einstein
Journal:  J Cardiovasc Magn Reson       Date:  2018-12-20       Impact factor: 5.364

3.  Buccal caffeine strips for reversal of adverse symptoms of vasodilator stress.

Authors:  Mohammed Elsadany; Bryan Stringer; Josiah Bote; Khaled H Abdulla; Jesse A Doran; Ronald G Schwartz; W Lane Duvall
Journal:  J Nucl Cardiol       Date:  2022-07-06       Impact factor: 3.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.